Autor: "Kim, K." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Genomic hypomethylation in cell-free DNA predicts responses to checkpoint blockade in lung and breast cancer.
Autorzy:: Kim K; Department of Bio and Brain Engineering, KAIST, Daejeon, Republic of Korea.
Kim H; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea.
Shin I; Penta Medix Co., Ltd, Seongnam-si, Gyeongi-do, Republic of Korea.
Noh SJ; Penta Medix Co., Ltd, Seongnam-si, Gyeongi-do, Republic of Korea.
Kim JY; Department of Bio and Brain Engineering, KAIST, Daejeon, Republic of Korea.
Suh KJ; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Gyeongi-do, Republic of Korea.
Kim YN; Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Lee JY; Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Cho DY; Penta Medix Co., Ltd, Seongnam-si, Gyeongi-do, Republic of Korea.
Kim SH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Gyeongi-do, Republic of Korea. .
Kim JH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Gyeongi-do, Republic of Korea. .
Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea. .; Department of Health Sciences and Technology, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, Republic of Korea. .
Choi JK; Department of Bio and Brain Engineering, KAIST, Daejeon, Republic of Korea. .; Penta Medix Co., Ltd, Seongnam-si, Gyeongi-do, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Dec 18; Vol. 13 (1), pp. 22482. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:: Journal Article
MeSH Terms:: Cell-Free Nucleic Acids*/genetics
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; Female ; Leukocytes, Mononuclear/pathology ; Genomics/methods ; Lung/pathology ; Biomarkers, Tumor/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centre.
Autorzy:: Sauvage LM; Department of Radiation Oncology, Institut Curie, Paris, France.
Loap P; Department of Radiation Oncology, Institut Curie, Paris, France.
Vu-Bezin J; Department of Radiation Oncology, Institut Curie, Paris, France.
Cao K; Department of Radiation Oncology, Institut Curie, Paris, France.
Kissel M; Department of Radiation Oncology, Institut Curie, Paris, France.
Bringer S; Department of Radiation Oncology, Institut Curie, Paris, France.
Maraadji S; Department of Radiation Oncology, Institut Curie, Paris, France.
Fourquet A; Department of Radiation Oncology, Institut Curie, Paris, France.
Kirova Y; Department of Radiation Oncology, Institut Curie, Paris, France.; University of Versailles St Quentin, Paris, France.; Pokaż więcej
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1791-1797. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:: Journal Article
MeSH Terms:: Mastectomy, Segmental*/adverse effects
Breast Neoplasms*/radiotherapy
Breast Neoplasms*/surgery
Breast Neoplasms*/drug therapy
Humans ; Female ; Radiotherapy, Adjuvant/adverse effects ; Radiotherapy, Adjuvant/methods ; Dose Fractionation, Radiation ; Follow-Up Studies ; Neoplasm Recurrence, Local/surgery

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: A metabolome-wide case-control study of african american breast cancer patients.
Autorzy:: Luo J; Department of Public Health Sciences, University of Chicago Biological Sciences, 5841 S. Maryland Ave. MC2000, 60637, Chicago, IL, USA.; Institute for Population and Precision Health, University of Chicago, Chicago, IL, USA.; Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
Kibriya MG; Department of Public Health Sciences, University of Chicago Biological Sciences, 5841 S. Maryland Ave. MC2000, 60637, Chicago, IL, USA.; Institute for Population and Precision Health, University of Chicago, Chicago, IL, USA.
Chen H; Mass Spectrometry Core, University of Illinois at Chicago, Chicago, IL, USA.
Kim K; Institute for Population and Precision Health, University of Chicago, Chicago, IL, USA.; Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.; Department of Medicine, University of Chicago, Chicago, IL, USA.
Ahsan H; Department of Public Health Sciences, University of Chicago Biological Sciences, 5841 S. Maryland Ave. MC2000, 60637, Chicago, IL, USA.; Institute for Population and Precision Health, University of Chicago, Chicago, IL, USA.; Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
Olopade OI; Department of Medicine, University of Chicago, Chicago, IL, USA.
Olopade CS; Department of Medicine, University of Chicago, Chicago, IL, USA.
Aschebrook-Kilfoy B; Department of Public Health Sciences, University of Chicago Biological Sciences, 5841 S. Maryland Ave. MC2000, 60637, Chicago, IL, USA. .; Institute for Population and Precision Health, University of Chicago, Chicago, IL, USA. .; Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA. .
Huo D; Department of Public Health Sciences, University of Chicago Biological Sciences, 5841 S. Maryland Ave. MC2000, 60637, Chicago, IL, USA. .; Institute for Population and Precision Health, University of Chicago, Chicago, IL, USA. .; Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA. .; Department of Medicine, University of Chicago, Chicago, IL, USA. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Feb 23; Vol. 23 (1), pp. 183. Date of Electronic Publication: 2023 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/metabolism
Metabolome*
Female ; Humans ; Black or African American ; Case-Control Studies ; Metabolomics/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance.
Autorzy:: Bhadwal P; Department of Biochemistry, Panjab University, Chandigarh, India.
Randhawa V; Department of Biochemistry, Panjab University, Chandigarh, India.; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Vaiphei K; Department of Histopathology, PGIMER, Chandigarh, India.
Dahiya D; Department of General Surgery, PGIMER, Chandigarh, India. .
Agnihotri N; Department of Biochemistry, Panjab University, Chandigarh, India. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Oct 29; Vol. 12 (1), pp. 18239. Date of Electronic Publication: 2022 Oct 29.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/metabolism
Female ; Humans ; Drug Resistance ; Phosphates ; Phosphotransferases (Alcohol Group Acceptor)/metabolism ; Sphingolipids

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: The Pattern of Care for Brain Metastasis from Breast Cancer over the Past 10 Years in Korea: A Multicenter Retrospective Study (KROG 16-12).
Autorzy:: Kim JS; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Kim K; Department of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Korea.
Jung W; Department of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Korea.
Shin KH; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Im SA; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kim HJ; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Kim YB; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Chang JS; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Kim JH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Choi DH; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Park YH; Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim DY; Proton Therapy Center, National Cancer Center, Goyang, Korea.
Kim TH; Proton Therapy Center, National Cancer Center, Goyang, Korea.
Choi BO; Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
Lee SW; Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.; Department of Radiation Oncology, Eunpyeong St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
Kim S; Department of Radiation Oncology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
Kwon J; Department of Radiation Oncology, Chungnam National University College of Medicine, Daejeon, Korea.
Kang KM; Department of Radiation Oncology, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, Changwon, Korea.
Chung WK; Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
Kim KS; Department of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Korea.; Department of Radiation Oncology, Dongnam Institute of Radiological and Medical Sciences, Busan, Korea.
Nam JH; Department of Radiation Oncology, Yangsan Pusan National University Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Yoon WS; Department of Radiation Oncology, Korea University Ansan Hospital, Korea University College of Medicine, Asan, Korea.
Kim JH; Department of Radiation Oncology, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.
Cha J; Department of Radiation Oncology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
Oh YK; Department of Radiation Oncology, Chosun University Medical School, Gwangju, Korea.
Kim IA; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, Korea.; Pokaż więcej
Źródło:: Cancer research and treatment [Cancer Res Treat] 2022 Oct; Vol. 54 (4), pp. 1121-1129. Date of Electronic Publication: 2021 Dec 31.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Brain Neoplasms*/epidemiology
Brain Neoplasms*/secondary
Brain Neoplasms*/therapy
Breast Neoplasms*/pathology
Radiosurgery*
Child, Preschool ; Female ; Humans ; Prognosis ; Republic of Korea/epidemiology ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Results and lessons from dual extraction of DNA and RNA from formalin-fixed paraffin-embedded breast tumor tissues for a large Cancer epidemiologic study.
Autorzy:: Ondracek RP; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA.
Chen J; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA. .
Marosy B; Center for Inherited Disease Research, Johns Hopkins Genomics, Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Szewczyk S; Department of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Medico L; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA.
Mohan AS; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA.
Nair P; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA.
Pratt R; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA.
Roh JM; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Khoury T; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Carpten J; Department of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Palmer JR; Slone Epidemiology Center, Boston University, Boston, MA, USA.
Doheny K; Center for Inherited Disease Research, Johns Hopkins Genomics, Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Davis W; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA.
Higgins MJ; Department of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Yao S; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA.
Ambrosone CB; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA.; Pokaż więcej
Źródło:: BMC genomics [BMC Genomics] 2022 Aug 25; Vol. 23 (1), pp. 614. Date of Electronic Publication: 2022 Aug 25.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/epidemiology
Breast Neoplasms*/genetics
RNA*/genetics
DNA/genetics ; Endopeptidase K ; Female ; Formaldehyde ; Humans ; Paraffin Embedding/methods ; Tissue Fixation/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Postmastectomy Radiation Therapy for Node-Negative Breast Cancer of 5 cm or Larger Tumors: A Multicenter Retrospective Analysis (KROG 20-03).
Autorzy:: Kim K; Department of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Korea.
Jung J; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim H; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jung W; Department of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Korea.
Shin KH; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Chang JH; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Kim SS; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Park W; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Chang JS; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Kim YB; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Ahn SJ; Department of Radiation Oncology, Chonnam National University Medical School, Gwangju, Korea.
Lee IJ; Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Lee JH; Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Park HJ; Department of Radiation Oncology, Hanyang University College of Medicine, Seoul, Korea.
Cha J; Department of Radiation Oncology, Yonsei University Wonju College of Medicine, Wonju, Korea.
Kim J; Department of Radiation Oncology, Cheil General Hospital and Women's Healthcare Center, Seoul, Korea.
Choi JH; Department of Radiology, Chung-Ang University College of Medicine, Seoul, Korea.
Koo T; Department of Radiation Oncology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.
Kwon J; Department of Radiation Oncology, Chungnam National University School of Medicine, Daejeon, Korea.
Kim JH; Department of Radiation Oncology, Keimyung University School of Medicine, Daegu, Korea.
Kim MY; Department of Radiation Oncology, Kyungpook National University Chilgok Hospital, Daegu, Korea.
Park SH; Department of Radiation Oncology, Kyungpook National University Hospital, Daegu, Korea.
Kim YJ; Proton Therapy Center, National Cancer Center, Goyang, Korea.; Pokaż więcej
Źródło:: Cancer research and treatment [Cancer Res Treat] 2022 Apr; Vol. 54 (2), pp. 497-504. Date of Electronic Publication: 2021 Aug 25.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Breast Neoplasms*/radiotherapy
Breast Neoplasms*/surgery
Female ; Humans ; Mastectomy ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Radiotherapy, Adjuvant ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Validation of Cancer Diagnosis Based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea.
Autorzy:: Yang MS; National Cancer Control Institute, National Cancer Center, Goyang, Korea.
Park M; National Cancer Control Institute, National Cancer Center, Goyang, Korea.
Back JH; Health Insurance Policy Research Institute, National Health Insurance Service, Wonju, Korea.
Lee GH; National Cancer Control Institute, National Cancer Center, Goyang, Korea.
Shin JH; National Cancer Control Institute, National Cancer Center, Goyang, Korea.
Kim K; National Cancer Control Institute, National Cancer Center, Goyang, Korea.
Seo HJ; Medical Informatics and Health Technology (MIT), Department of Health Care Management, Gachon University, Seongnam, Korea.
Kim YA; National Cancer Control Institute, National Cancer Center, Goyang, Korea.; Pokaż więcej
Źródło:: Cancer research and treatment [Cancer Res Treat] 2022 Apr; Vol. 54 (2), pp. 352-361. Date of Electronic Publication: 2021 Aug 02.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/diagnosis
Breast Neoplasms*/epidemiology
National Health Programs*
Databases, Factual ; Female ; Humans ; Registries ; Republic of Korea/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort.
Autorzy:: His M; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 150 cours Albert Thomas, 69372, CEDEX 08, Lyon, France.
Viallon V; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 150 cours Albert Thomas, 69372, CEDEX 08, Lyon, France.
Dossus L; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 150 cours Albert Thomas, 69372, CEDEX 08, Lyon, France.
Schmidt JA; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Travis RC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Gunter MJ; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 150 cours Albert Thomas, 69372, CEDEX 08, Lyon, France.
Overvad K; Department of Public Health, Aarhus University, Aarhus, Denmark.
Kyrø C; Danish Cancer Society Research Center, Copenhagen, Denmark.
Tjønneland A; Danish Cancer Society Research Center, Copenhagen, Denmark.; Department of Public Health, Section of Environmental Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Lécuyer L; Université Paris-Saclay, UVSQ, Inserm, CESP U1018, 'Exposome and Heredity' team, Gustave Roussy, Villejuif, France.
Rothwell JA; Université Paris-Saclay, UVSQ, Inserm, CESP U1018, 'Exposome and Heredity' team, Gustave Roussy, Villejuif, France.
Severi G; Université Paris-Saclay, UVSQ, Inserm, CESP U1018, 'Exposome and Heredity' team, Gustave Roussy, Villejuif, France.; Department of Statistics, Computer Science, Applications 'G. Parenti', University of Florence, Florence, Italy.
Johnson T; Department of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Katzke V; Department of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Schulze MB; Department of Molecular Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.; Institute of Nutritional Science, University of Potsdam, Potsdam, Germany.
Masala G; Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Sieri S; Epidemiology and Prevention Unit, Fondazione IRCCS Instituto Nazionale dei Tumori di Milano, Milan, Italy.
Panico S; Dipartimento Di Medicina Clinica E Chirurgia, Federico Ii University, Naples, Italy.
Tumino R; Cancer Registry and Histopathology Department, Provincial Health Authority (ASP 7) Ragusa, Ragusa, Italy.
Macciotta A; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Boer JMA; Center for Nutrition, Prevention, and Health Services, National Institute for Public Health and the Environment (RIVM), Bilthoven, 3720, BA, the Netherlands.
Monninkhof EM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Olsen KS; Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, NO-9037, Tromsø, Norway.
Nøst TH; Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, NO-9037, Tromsø, Norway.
Sandanger TM; Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, NO-9037, Tromsø, Norway.
Agudo A; Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, L'Hospitalet de Llobregat, Spain.; Nutrition and Cancer Group; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program; Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet de Llobregat, Spain.
Sánchez MJ; Escuela Andaluza de Salud Pública (EASP), Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
Amiano P; Ministry of Health of the Basque Government, Sub-Directorate for Public Health and Addictions of Gipuzkoa, San Sebastián, Spain.; Biodonostia Health Research Institute, Group of Epidemiology of Chronic and Communicable Diseases, San Sebastián, Spain.; CIBER Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Colorado-Yohar SM; CIBER Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.; Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellín, Colombia.
Ardanaz E; CIBER Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Navarra Public Health Institute, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
Vidman L; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Winkvist A; Sustainable Health, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Heath AK; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Weiderpass E; International Agency for Research on Cancer (IARC/WHO), Office of the Director, Lyon, France.
Huybrechts I; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 150 cours Albert Thomas, 69372, CEDEX 08, Lyon, France.
Rinaldi S; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 150 cours Albert Thomas, 69372, CEDEX 08, Lyon, France. .; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2021 Dec 10; Vol. 19 (1), pp. 312. Date of Electronic Publication: 2021 Dec 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/epidemiology
Cohort Studies ; Cross-Sectional Studies ; Female ; Humans ; Life Style ; Prospective Studies ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Cognitive Dysfunction: Feasibility of a Brief Intervention to Help Breast Cancer Survivors.
Autorzy:: Radomski M
Kreiger R
Anheluk M
Berling K
Darger M
Garcia H
Grabe K
Hopkins S
Morrison M
Zola J
Swenson KK; Park Nicollet Institute, Minneapolis, MN.; Pokaż więcej
Źródło:: Clinical journal of oncology nursing [Clin J Oncol Nurs] 2021 Dec 01; Vol. 25 (6), pp. E69-E76.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/psychology
Cancer Survivors*/psychology
Cognitive Dysfunction*/etiology
Cognitive Dysfunction*/therapy
Crisis Intervention ; Feasibility Studies ; Female ; Humans ; Quality of Life

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Prognostic value of metabolic activity of the psoas muscle evaluated by preoperative F-FDG PET-CT in breast cancer: a retrospective cross-sectional study.
Autorzy:: Kim K; Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea.
Kim IJ; Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea.
Pak K; Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea.
Kang T; Department of Surgery, Busan Cancer Center, Pusan National University Hospital and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea.
Seol YM; Department of Hematology-Oncology, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan, 49241, South Korea.
Choi YJ; Department of Hematology-Oncology, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan, 49241, South Korea.
Kim H; Department of Hematology-Oncology, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan, 49241, South Korea. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Oct 27; Vol. 21 (1), pp. 1151. Date of Electronic Publication: 2021 Oct 27.
Typ publikacji:: Journal Article
MeSH Terms:: Insulin Resistance*
Positron Emission Tomography Computed Tomography*
Breast Neoplasms/*metabolism
Carcinoma, Ductal, Breast/*metabolism
Fluorodeoxyglucose F18/*pharmacokinetics
Psoas Muscles/*metabolism
Radiopharmaceuticals/*pharmacokinetics
Adult ; Aged ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Carcinoma, Ductal, Breast/diagnostic imaging ; Carcinoma, Ductal, Breast/pathology ; Carcinoma, Ductal, Breast/surgery ; Cross-Sectional Studies ; Female ; Humans ; Liver/metabolism ; Mastectomy ; Middle Aged ; Neoplasm Recurrence, Local ; Preoperative Care ; Prognosis ; Proportional Hazards Models ; Retrospective Studies ; Sensitivity and Specificity ; Treatment Outcome ; Triple Negative Breast Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: A protein interaction landscape of breast cancer.
Autorzy:: Kim M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Park J; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, CA, USA.
Bouhaddou M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Kim K; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Rojc A; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Modak M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Soucheray M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
McGregor MJ; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
O'Leary P; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Wolf D; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Stevenson E; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Foo TK; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Mitchell D; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Division of Hematology/Oncology, University of California, San Francisco, CA, USA.
Herrington KA; Department of Biochemistry and Biophysics, Center for Advanced Light Microscopy, University of California, San Francisco, CA, USA.
Muñoz DP; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Tutuncuoglu B; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Chen KH; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Zheng F; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, CA, USA.
Kreisberg JF; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, CA, USA.
Diolaiti ME; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Gordan JD; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Division of Hematology/Oncology, University of California, San Francisco, CA, USA.
Coppé JP; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Swaney DL; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Xia B; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
van 't Veer L; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Ashworth A; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Ideker T; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, CA, USA.; Department of Bioengineering, University of California, San Diego, CA, USA.
Krogan NJ; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2021 Oct; Vol. 374 (6563), pp. eabf3066. Date of Electronic Publication: 2021 Oct 01.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Protein Interaction Maps*
Breast Neoplasms/*metabolism
Neoplasm Proteins/*metabolism
Breast Neoplasms/genetics ; Cell Line, Tumor ; Female ; Humans ; Mass Spectrometry ; Mutation ; Neoplasm Proteins/genetics ; Neoplasm Proteins/isolation & purification ; Tandem Affinity Purification

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: 18F-Fluoroestradiol PET in the evaluation of probable oligometastatic breast cancer.
Autorzy:: Denton M; Department of Medical Imaging, St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
Taubman K; Department of Medical Imaging, St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
Sutherland T; Department of Medical Imaging, St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.; Pokaż więcej
Źródło:: Journal of medical imaging and radiation oncology [J Med Imaging Radiat Oncol] 2021 Jun; Vol. 65 (3), pp. 333-334. Date of Electronic Publication: 2020 Dec 26.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/diagnostic imaging
Estradiol ; Humans ; Male ; Positron Emission Tomography Computed Tomography ; Positron-Emission Tomography ; Receptors, Estrogen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Effect of tamoxifen with or without gonadotropin-releasing hormone analog on DXA values in women with breast cancer.
Autorzy:: Kim EH; Division of Endocrinology and Metabolism, Department of Internal Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Jeon YK; Division of Endocrinology and Metabolism, Department of Internal Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Pak K; Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital and School of Medicine, Pusan National University, Busan, Republic of Korea.
Kang T; Busan Cancer Center (Breast Cancer Clinic) and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Kim KE; Busan Cancer Center (Breast Cancer Clinic) and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Kim SJ; Department of Nuclear Medicine and Research Institute for Convergence of Biomedical Science and Technology, Yangsan Pusan National University Hospital, Yangsan, Republic of Korea.
Kim IJ; Division of Endocrinology and Metabolism, Department of Internal Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.; Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital and School of Medicine, Pusan National University, Busan, Republic of Korea.
Kim K; Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital and School of Medicine, Pusan National University, Busan, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Feb 09; Vol. 11 (1), pp. 3407. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Absorptiometry, Photon*
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/metabolism
Breast Neoplasms*/therapy
Cancellous Bone*/diagnostic imaging
Cancellous Bone*/metabolism
Mastectomy*
Bone Density/*drug effects
Gonadotropin-Releasing Hormone/*administration & dosage
Tamoxifen/*administration & dosage
Adult ; Aged ; Cross-Sectional Studies ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Postmenopause ; Premenopause ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Physical activity status in relation to quality of life and dietary habits in breast cancer survivors: subset analyses of KROG 14-09 nationwide questionnaire study.
Autorzy:: Ahn SJ; Radiation Oncology, Chonnam National Univiersity Hwasun Hospital, Hwasun, Jeollanam-do, Republic of Korea.
Kim JH; Radiation Oncology, Dongsan Medical Center, Keimyung University, Daegu, Republic of Korea.
Chun M; Radiation Oncology, Ajou University, Suwon, Gyeonggi-do, Republic of Korea.
Yoon WS; Department of Radiation Oncology, Ansan Hospital, Korea University, 123 Jeokgeum-ro, Danwon-gu, Ansan, 15355, Gyeonggi-do, Republic of Korea. .
Rim CH; Department of Radiation Oncology, Ansan Hospital, Korea University, 123 Jeokgeum-ro, Danwon-gu, Ansan, 15355, Gyeonggi-do, Republic of Korea.
Yang DS; Radiation Oncology, Guro Hospital, Korea University, Seoul, Republic of Korea.
Lee JH; Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Kim K; Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea.; Radiation Oncology, Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Republic of Korea.
Kong M; Radiation Oncology, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Republic of Korea.
Kim S; Radiation Oncology, Boramae Medical Center, Seoul National University, Seoul, Republic of Korea.
Kim J; Radiation Oncology, Ilsancha Hospital, Cha Medical Center, Goyang, Gyeonggi-do, Republic of Korea.
Park KR; Radiation Oncology, Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Republic of Korea.
Shin YJ; Radiation Oncology, Sanggye Paik Hospital, Inje University, Seoul, Republic of Korea.
Ma SY; Radiation Oncology, Kosin University Gospel Hospital, Busan, Republic of Korea.
Jeong BK; Radiation Oncology, Gyeongsang National University School of Medicine and Gyeongsang National Univeristy Hospital, Jinju, Gyeongsangnam-do, Republic of Korea.
Kim SS; Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim YB; Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
Lee DS; Radiation Oncology, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Uijeongbu, Gyeonggi-do, Republic of Korea.; Pokaż więcej
Źródło:: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2020 Dec; Vol. 29 (12), pp. 3353-3361. Date of Electronic Publication: 2020 Jul 23.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms/*psychology
Breast Neoplasms/*therapy
Exercise/*psychology
Feeding Behavior/*psychology
Quality of Life/*psychology
Adolescent ; Adult ; Cancer Survivors ; Female ; Humans ; Surveys and Questionnaires ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Prospective evaluation of the impact of stress, anxiety, and depression on household income among young women with early breast cancer from the Young and Strong trial.
Autorzy:: Cook EE; Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Current affiliation: Analysis Group, Inc., Boston, MA, USA.
Rosenberg SM; Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.
Ruddy KJ; Mayo Clinic, Rochester, MN, USA.
Barry WT; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
Greaney M; University of Rhode Island, Kingston, RI, USA.
Ligibel J; Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.
Sprunck-Harrild K; Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
Holmes MD; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Tamimi RM; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Emmons KM; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. Ann_.; Harvard Medical School, Boston, MA, USA. Ann_.; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2020 Oct 06; Vol. 20 (1), pp. 1514. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji:: Journal Article
MeSH Terms:: Anxiety/*economics
Breast Neoplasms/*psychology
Cancer Survivors/*psychology
Depression/*economics
Income/*statistics & numerical data
Stress, Psychological/*economics
Adolescent ; Adult ; Anxiety/etiology ; Breast Neoplasms/economics ; Clinical Trials as Topic ; Depression/etiology ; Female ; Humans ; Longitudinal Studies ; Middle Aged ; Prospective Studies ; Quality of Life/psychology ; Stress, Psychological/etiology ; United States ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Is radial scar on core needle biopsy a risk factor for malignancy? A single-center retrospective review and implications for management.
Autorzy:: Woodward SG; Department of Surgery, Thomas Jefferson University Hospital, Sidney Kimmel Medical College, Philadelphia University and Thomas Jefferson University, Philadelphia, PA, USA.
Nimtz K; Sidney Kimmel Medical College, Philadelphia University and Thomas Jefferson University, Philadelphia, PA, USA.
Hookim K; Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University Hospital, Sidney Kimmel Medical College, Philadelphia University and Thomas Jefferson University, Philadelphia, PA, USA.
Sevrukov AB; Department of Radiology, Thomas Jefferson University Hospital, Sidney Kimmel Medical College, Philadelphia University and Thomas Jefferson University, Philadelphia, PA, USA.
Tsangaris TN; Department of Surgery, Thomas Jefferson University Hospital, Sidney Kimmel Medical College, Philadelphia University and Thomas Jefferson University, Philadelphia, PA, USA.; Cancer Center, Calvert Health, Prince Frederick, MD, USA.
Willis A; Department of Surgery, Thomas Jefferson University Hospital, Sidney Kimmel Medical College, Philadelphia University and Thomas Jefferson University, Philadelphia, PA, USA.
Berger AC; Department of Surgery, Thomas Jefferson University Hospital, Sidney Kimmel Medical College, Philadelphia University and Thomas Jefferson University, Philadelphia, PA, USA.; Department of Surgery, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Lazar M; Department of Surgery, Thomas Jefferson University Hospital, Sidney Kimmel Medical College, Philadelphia University and Thomas Jefferson University, Philadelphia, PA, USA.; Pokaż więcej
Źródło:: The breast journal [Breast J] 2020 Oct; Vol. 26 (10), pp. 2011-2014. Date of Electronic Publication: 2020 Jul 13.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/surgery
Cicatrix*/etiology
Cicatrix*/pathology
Biopsy, Large-Core Needle ; Female ; Humans ; Retrospective Studies ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Dynamic and subtype-specific interactions between tumour burden and prognosis in breast cancer.
Autorzy:: Lee SB; Division of Breast Surgery, Department of Surgery, Asan Medical Centre, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Kim HK; Department of Surgery, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul, 110-744, Korea.; Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Choi Y; Medical Research Collaborating Centre, Seoul National University Hospital, Seoul, Korea.
Ju YW; Department of Surgery, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul, 110-744, Korea.
Lee HB; Department of Surgery, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul, 110-744, Korea.
Han W; Department of Surgery, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul, 110-744, Korea.
Noh DY; Department of Surgery, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul, 110-744, Korea.
Son BH; Division of Breast Surgery, Department of Surgery, Asan Medical Centre, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Ahn SH; Division of Breast Surgery, Department of Surgery, Asan Medical Centre, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Kim KS; Breast-Thyroid Centre, Ulsan City Hospital, Ulsan, Korea.
Nam SJ; Division of Breast Surgery, Department of Surgery, Samsung Medical Centre, Seoul, Korea.
Kim EK; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Park HY; Department of Surgery, School of Medicine, Kyungpook National University, Daegu, Korea.
Park WC; Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, Asan Medical Centre, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea. .
Moon HG; Department of Surgery, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul, 110-744, Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2020 Sep 22; Vol. 10 (1), pp. 15445. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Tumor Burden*
Breast Neoplasms/*classification
Breast Neoplasms/*pathology
Receptor, ErbB-2/*metabolism
Receptors, Estrogen/*metabolism
Receptors, Progesterone/*metabolism
Adolescent ; Adult ; Aged ; Biomarkers, Tumor/metabolism ; Breast Neoplasms/metabolism ; Breast Neoplasms/therapy ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Neoplasm Metastasis ; Prognosis ; Survival Rate ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Homologous repair deficiency score for identifying breast cancers with defective DNA damage response.
Autorzy:: Min A; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
Kim K; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
Jeong K; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
Choi S; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
Kim S; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
Suh KJ; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul, Republic of Korea.
Lee KH; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea. .; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. .
Kim S; Department of Computer Science and Engineering, Seoul National University, Seoul, Republic of Korea.; Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, Republic of Korea.; Bioinformatics Institute, Seoul National University, Seoul, Republic of Korea.
Im SA; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea. .; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea. .; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. .; Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2020 Jul 27; Vol. 10 (1), pp. 12506. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: DNA Damage*/genetics
DNA Repair*
Homologous Recombination*/genetics
Breast Neoplasms/*genetics
Breast Neoplasms/*pathology
BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Breast Neoplasms, Male/genetics ; Breast Neoplasms, Male/pathology ; Female ; Germ-Line Mutation/genetics ; Humans ; Male

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: The feasibility of quantitative parameters of lymphoscintigraphy without significant dermal backflow for the evaluation of lymphedema in post-operative patients with breast cancer.
Autorzy:: Kim K; Department of Nuclear Medicine, Pusan National University Hospital and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Kim IJ; Department of Nuclear Medicine, Pusan National University Hospital and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Pak K; Department of Nuclear Medicine, Pusan National University Hospital and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Kim SJ; Department of Nuclear Medicine and Research Institute for Convergence of Biomedical Science and Technology, Yangsan Pusan National University Hospital, Yangsan, Republic of Korea.
Choi SJ; Department of Nuclear Medicine, Pusan National University Hospital and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Park H; Department of Surgery, Busan Cancer Center, Pusan National University Hospital and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Kang T; Department of Surgery, Busan Cancer Center, Pusan National University Hospital and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Kong IJ; Department of Rehabilitation Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Gudeok-Ro Seo-Gu, Busan, 602-739, South Korea.
Shin YB; Department of Rehabilitation Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Gudeok-Ro Seo-Gu, Busan, 602-739, South Korea.
Kim H; Department of Hemato-oncology, Pusan National University Hospital and Pusan National University School of Medicine, Busan, Republic of Korea.
Yoon JA; Department of Rehabilitation Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Gudeok-Ro Seo-Gu, Busan, 602-739, South Korea. .; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2020 May; Vol. 47 (5), pp. 1094-1102. Date of Electronic Publication: 2019 Nov 16.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/surgery
Lymphedema*/diagnostic imaging
Lymphedema*/etiology
Axilla ; Feasibility Studies ; Humans ; Lymph Node Excision ; Lymphoscintigraphy ; Mastectomy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Kim, K."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język